---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-025171"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2026-05-26T12:30:22+00:00"
generated_at: "2026-05-26T12:35:18.868478+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical receives Israeli regulatory approval for LIBERTY System, first outside U.S.

## Summary
- Israeli Ministry of Health's AMAR Division grants marketing clearance for LIBERTY Endovascular Robotic System in Israel.
- First regulatory approval outside the U.S.; enables Free Sale Certificate for submissions in other jurisdictions.
- Company targets CE Mark certification by end of 2026 for EU market expansion.
- System adopted by multiple U.S. accounts in GA, FL, NY, MA, MI, NC.
- Advanced discussions underway to expedite commercialization in Israel.

## SEC filing metadata
- accession: 0001493152-26-025171
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2026-05-26T12:30:22+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000149315226025171/0001493152-26-025171-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000149315226025171/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-025171
- JSON: https://secwatch.observer/filing/0001493152-26-025171.json
- Plain text: https://secwatch.observer/filing/0001493152-26-025171.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.